| 000 | 01876 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513062045.0 | ||
| 264 | 0 | _c19940412 | |
| 008 | 199404s 0 0 eng d | ||
| 022 | _a0340-7004 | ||
| 024 | 7 |
_a10.1007/BF01525635 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFagerberg, J | |
| 245 | 0 | 0 |
_aInduction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy? _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cMar 1994 |
||
| 300 |
_a149-59 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Tumor-Associated, Carbohydrate _xtherapeutic use |
| 650 | 0 | 4 |
_aColorectal Neoplasms _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity, Delayed _ximmunology |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 |
_aImmunoglobulin Idiotypes _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Fusion Proteins |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aFrödin, J E | |
| 700 | 1 | _aRagnhammar, P | |
| 700 | 1 | _aSteinitz, M | |
| 700 | 1 | _aWigzell, H | |
| 700 | 1 | _aMellstedt, H | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 38 _gno. 3 _gp. 149-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01525635 _zAvailable from publisher's website |
| 999 |
_c8124007 _d8124007 |
||